ReviewMicrobial cell factories2024
Strategies for improving fengycin production: a review.
Review in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Research Progress on Bioactive Peptides From Diverse Sources: Preparation, Structure-Activity Relationship, and Applications.Journal of food science · 2026Review
- A Promising Strain for Wheat Growth Promotion and Antifungal Activity Against Fungal Phytopathogens:Microorganisms · 2026Article
- Small non-coding RNAMicrobiology spectrum · 2026Article
- Biocontrol of mushroom crop mycoparasites by novel Bacillus velezensis strains.Applied microbiology and biotechnology · 2026Article
- Metabolic Flux Analysis Reveals Entner-Doudoroff Pathway Dominance in Heterotrophic Deep-Sea Bacterial Isolates.Environmental microbiology reports · 2026Article
- Biocontrol of mushroom crop mycoparasites by novelbioRxiv : the preprint server for biology · 2026Article
- Kinetic modeling of multiple-strain artificial consortium to improve fengycin production of Bacillus subtilis.Biotechnology for biofuels and bioproducts · 2026Article
- Complete genome sequence and functional characterization of Bacillus amyloliquefaciens NJF-55: a sheep-derived probiotic candidate.Scientific reports · 2026Article
- Whole genome analysis, fermentation process, and development of plant functional microbial fertilizer for Bacillus velezensis YU18 in mangrove.Antonie van Leeuwenhoek · 2026Article
- Article
- Comparative genome mining and metabolomics reveal divergent NRPS-derived fengycin biosynthetic gene clusters inFEMS microbes · 2026Article
- Genomic insights into biosynthetic gene cluster diversity and structural variability in marine bacteria.Scientific reports · 2025Article
- Complete genome analysis and antimicrobial mechanism ofMicrobiology spectrum · 2025Article
- Biocontrol Effect ofMicroorganisms · 2025Article
- Bio-Based Surfactants and Biosurfactants: An Overview and Main Characteristics.Molecules (Basel, Switzerland) · 2025Review
- Antimicrobial Activity ofInternational journal of molecular sciences · 2025Review
- Psychrotrophic Antarctic marine bacteria as potential reservoirs for novel antimicrobial genes.FEMS microbes · 2025Article
- Article
- Identification and Bioactivity Analysis of a NovelAntibiotics (Basel, Switzerland) · 2024Article
- Effects of branched-chain amino acids on surfactin structure and antibacterial activity in Bacillus velezensis YA215.World journal of microbiology & biotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fengycin is an important member of the lipopeptide family with a wide range of applications in the agricultural, food, medical and cosmetic industries. However, its commercial application is severely hindered by low productivity and high cost. Therefore, numerous studies have been devoted to improving the production of fengycin. We summarize these studies in this review with the aim of providing a reference and guidance for future researchers. This review begins with an overview of the synthesis mechanism of fengycin via the non-ribosomal peptide synthetases (NRPS), and then delves into the strategies for improving the fengycin production in recent years. These strategies mainly include fermentation optimization and metabolic engineering, and the metabolic engineering encompasses enhancement of precursor supply, application of regulatory factors, promoter engineering, and application of genome-engineering (genome shuffling and genome-scale metabolic network model). Finally, we conclude this review with a prospect of fengycin production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.